======= KMT2C ======= == Gene Information == * **Official Symbol**: KMT2C * **Official Name**: lysine methyltransferase 2C * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=58508|58508]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NEZ4|Q8NEZ4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KMT2C&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KMT2C|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606833|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]. * **UniProt Summary**: Histone methyltransferase. Methylates 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Central component of the MLL2/3 complex, a coactivator complex of nuclear receptors, involved in transcriptional coactivation. KMT2C/MLL3 may be a catalytic subunit of this complex. May be involved in leukemogenesis and developmental disorder. {ECO:0000269|PubMed:17500065}. |FYRC| |FYRN| |SET| |PHD| |MLL3/4 complex| |histone methyltransferase activity (H3-K4 specific)| |transferase activity, transferring acyl groups| |histone H3-K4 methylation| |histone methyltransferase complex| |regulation of megakaryocyte differentiation| |histone lysine methylation| |peptidyl-lysine methylation| |histone methylation| |histone binding| |protein alkylation| |protein methylation| |regulation of myeloid cell differentiation| |macromolecule methylation| |transcription coactivator activity| |methylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |regulation of hemopoiesis| |chromatin organization| |peptidyl-amino acid modification| |chromosome organization| |positive regulation of transcription by RNA polymerase II| |RNA binding| |DNA binding| |positive regulation of transcription, DNA-templated| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |positive regulation of RNA metabolic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp285|GW501516 25μM R06 exp285]]|-1.75| |[[:results:exp169|BH1 1μM R04 exp169]]|-1.73| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.78| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.91| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3638 * **Expression level (log2 read counts)**: 7.24 {{:chemogenomics:nalm6 dist.png?nolink |}}